There are encouraging signs that people in treatment for drug addiction can manage their medication when they are entrusted with a substantial quantity of opiate substitutes and told to take it in small daily doses, finds a new ‘early insight’ report from researchers at the Universities of Bristol and Bath
Bibliography: Interventions – Treatment
Adult substance misuse treatment statistics 2019 to 2020: report
The number of people in treatment for opiate use was similar to the previous year (going up slightly from 139,845 to 140,599). Over half (52%) the adults in treatment were there for problems with opiates, and this remains the largest substance group (PHE)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 2
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Prevention and Treatment of HIV Among People Living with Substance Use and/or Mental Disorders
This guide reviews effective programs and practices to prevent HIV and increase adherence to and retention in care (SAMHSA)
EMCDDA releases study findings on the impact of COVID-19 on drug markets, use and services in the eastern ENP region
The expansion of contactless drug dealing, the increase in the use of licit drugs and the adaptation of drug treatment protocols during lockdown are among the findings highlighted today in a new EMCDDA report: Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in east European Neighbourhood Policy countries
COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol
This guidance outlines COVID-19 advice for commissioners and service providers involved in assisting people who are dependent on drugs or alcohol or both (Public Health England)
The National Survey on Drug Use and Health: 2019 (PDF)
NSDUH is a comprehensive household interview survey of substance use, substance use disorders, mental health, and the receipt of treatment services for these disorders in the United States (SAMHSA)
Does it matter where you get medication for opioid use disorder? A comparison of three types of clinics
Do substance-related outcomes vary across different types of community clinics? (Recovery Research Institute)
Substance use disorder recovery – there’s an app for that… but who uses it and who benefits?
To begin to address this gap in the clinical literature, the authors conducted an analysis of Sober Grid, a popular substance use disorder (SUD) recovery smartphone application (Recovery Research Institute)
Managing drug and alcohol misuse at work
Our report, written with input from charities and experts in the space, examines the management and prevention of drug and alcohol misuse at work (CIPD)
United Kingdom drug situation: Focal Point annual report
Annual report and data tables from the UK Focal Point on Drugs on the national prevalence, impact, prevention and treatment of drug use (PHE)
United Kingdom drug situation: Focal Point annual report
Annual report and data tables from the UK Focal Point on Drugs on the national prevalence, impact, prevention and treatment of drug use (Home Office)
Care for Veterans with Substance Use and Mental Health Disorders Requires Improvement
Veterans who have served in the U.S. military since the 9/11 attacks have a high level of need for both substance use treatment and mental health care, yet many do not receive appropriate help for their co-occurring disorders, according to a new RAND Corporation report
Medicinal Use of Psilocybin: Reducing restrictions on research and treatment
The Adam Smith Institute, in conjunction with the Conservative Drug Policy Reform Group (CDPRG), has published a new report outlining the medical potential of psilocybin and the need to reduce restrictions on research and treatmen
A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report
This report describes the development of a national model of remote care to eliminate waiting lists and increase access to OAT in Ireland (BMC)
Prescription Opioids (Canadian Drug Summary)
Summarizes data on the use of prescription opioids, including information on associated harms and effects, legal status, costs, hospitalization, emergency department visits and access to treatment (CCSA)
Drug treatment in Ireland 2013 to 2019
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland (HRB)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Addiction Services in Northern Ireland
This report provides an overview of the scale of alcohol and drug addiction in Northern Ireland, the structures and systems in place within the health sector for tackling addiction, and the challenges faced by those accessing addiction services (NIAO)
Drugs, Prisons and ‘Unintended Consequences’ – Does drug interdiction drive drug-related harms?
The availability and use of drugs in prisons cannot be separated from wider drug policy. The criminalisation of drugs and the people who use or sell them fuels mass incarceration in many countries, and in doing so creates large profitable markets for drugs behind bars (Gdpo)
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 17
- Next Page »
